BACKGROUND: Anti-müllerian hormone (AMH) is secreted from granulosa cells of antral follicles into the circulation of adult women and hence could serve as an ovarian function test. This would be of value to hormonal contraceptive users if its serum level is unaffected by the use of hormonal contraceptives. STUDY DESIGN: We prospectively recruited 95 women using combined oral contraceptive (n=23), combined injectable contraceptive (n=23), progestogen-only pills (n=9), progestogen-only injectable (n=20) and levonorgestrel intrauterine system (n=20), and measured their serum AMH concentration before and 3-4 months after treatment. RESULTS: No significant difference in pre- and post-treatment serum AMH level was evident in all the treatment groups studied. CONCLUSIONS: Being unaffected by hormonal contraceptives, serum AMH measurement is potentially a useful clinical test in hormonal contraceptive users for the differential diagnosis of anovulatory disorders and determination of menopause.
BACKGROUND: Anti-müllerian hormone (AMH) is secreted from granulosa cells of antral follicles into the circulation of adult women and hence could serve as an ovarian function test. This would be of value to hormonal contraceptive users if its serum level is unaffected by the use of hormonal contraceptives. STUDY DESIGN: We prospectively recruited 95 women using combined oral contraceptive (n=23), combined injectable contraceptive (n=23), progestogen-only pills (n=9), progestogen-only injectable (n=20) and levonorgestrel intrauterine system (n=20), and measured their serum AMH concentration before and 3-4 months after treatment. RESULTS: No significant difference in pre- and post-treatment serum AMH level was evident in all the treatment groups studied. CONCLUSIONS: Being unaffected by hormonal contraceptives, serum AMH measurement is potentially a useful clinical test in hormonal contraceptive users for the differential diagnosis of anovulatory disorders and determination of menopause.
Authors: Rebecca Scherzer; Peter Bacchetti; Geralyn Messerlian; Johanna Goderre; Pauline M Maki; David B Seifer; Kathryn Anastos; Roksana Karim; Ruth M Greenblatt Journal: Am J Reprod Immunol Date: 2014-10-23 Impact factor: 3.886
Authors: Z Heidar; M Bakhtiyari; M Mirzamoradi; S Zadehmodarres; F S Sarfjoo; M A Mansournia Journal: J Endocrinol Invest Date: 2015-05-17 Impact factor: 4.256
Authors: Lauren N C Johnson; Mary D Sammel; Katherine E Dillon; Lara Lechtenberg; Allison Schanne; Clarisa R Gracia Journal: Fertil Steril Date: 2014-06-14 Impact factor: 7.329
Authors: Hang Wun Raymond Li; Ernest Hung Yu Ng; Benancy Po Chau Wong; Richard A Anderson; Pak Chung Ho; William Shu Biu Yeung Journal: J Assist Reprod Genet Date: 2012-11-02 Impact factor: 3.412
Authors: Kristen A Hahn; Elizabeth E Hatch; Kenneth J Rothman; Ellen M Mikkelsen; Susan B Brogly; Henrik T Sørensen; Anders H Riis; Lauren A Wise Journal: Ann Epidemiol Date: 2015-09-14 Impact factor: 3.797
Authors: Erica E Marsh; Lia A Bernardi; Marissa L Steinberg; Peter J de Chavez; Jenny A Visser; Mercedes R Carnethon; Donna D Baird Journal: Fertil Steril Date: 2016-04-23 Impact factor: 7.329
Authors: Katherine E Dillon; Mary D Sammel; Maureen Prewitt; Jill P Ginsberg; Dana Walker; Jennifer E Mersereau; Yasmin Gosiengfiao; Clarisa R Gracia Journal: Fertil Steril Date: 2012-10-18 Impact factor: 7.329
Authors: Christine R Langton; Brian W Whitcomb; Alexandra C Purdue-Smithe; Lynnette L Sievert; Susan E Hankinson; JoAnn E Manson; Bernard A Rosner; Elizabeth R Bertone-Johnson Journal: Menopause Date: 2021-12-06 Impact factor: 2.953